State caps on insulin costs lowered privately insured patients' out-of-pocket spending, but they didn't appear to increase insulin use, according to a new Annals of Internal Medicine study.
Today, the same justices who undid constitutional protection for abortion will hear arguments in the next frontier of abortion restriction: tightening access across the country for a medication that's used in nearly two-thirds of all abortions nationally.
Novo Nordisk said Monday it had agreed to buy Cardior Pharmaceuticals for up to 1.03 billion euros ($1.1 billion) to strengthen its cardiovascular pipeline.